alpha-MSH is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-14. Numbers and descriptions here follow the published literature rather than marketing material.
Identity testing for a synthetic peptide relies on several complementary methods. Reversed-phase high-performance liquid chromatography separates the target from related impurities and reports purity as a percentage of total peak area. Mass spectrometry confirms molecular mass and can reveal deletions or truncations. Amino acid analysis and peptide mapping provide sequence-level confirmation, while counter-ion content and residual solvents are measured separately. A purity figure alone does not establish identity, so a complete dataset combines chromatographic and spectrometric evidence.
Lyophilized peptide powder is generally stored frozen, protected from light and moisture. Tryptophan residues are susceptible to oxidation, and the lactam bridge can hydrolyze under strongly acidic or basic conditions. Solutions prepared for laboratory work degrade faster than dry powder, and repeated freeze-thaw cycles accelerate loss. Common practice is to aliquot solutions before freezing and to avoid alkaline buffers. Reported stability windows vary with concentration, buffer, and temperature, so exact shelf lives are method-specific rather than universal.
Melanotan-2 is a synthetic linear peptide built from seven amino acids arranged in a short chain. Its sequence is commonly written as Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2, which includes a modified N-terminus and an amidated C-terminus. The molecule belongs to the melanocortin family and acts as a receptor agonist. Structural features such as the D-phenylalanine residue and the Nle substitution are associated with increased stability against enzymatic degradation relative to the natural parent peptide.
The compound emerged from research programs in the 1980s that examined analogues of alpha-melanocyte-stimulating hormone for pigmentation and photoprotection. Investigators modified the native sequence to extend activity duration and potency. A related analogue, afamelanotide, was developed within the same broad line of inquiry and eventually gained approval in certain jurisdictions for a rare light-sensitivity condition. Melanotan-2 itself did not progress through the same regulatory route and has no approved therapeutic indication.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Free base; salt forms differ |
| Molecular mass | About 1024.2 g/mol | Monoisotopic value for the free base |
| Appearance | White to off-white lyophilized powder | Visual inspection is not an identity test |
| Solubility | Soluble in water and polar organic solvents | Dissolution depends on salt form and pH |
| Typical storage | -20 °C, dry, protected from light | Powder is more stable than prepared solutions |
Reversed-phase high-performance liquid chromatography is the routine method for purity assessment. Peptides absorb near 214 nm because of the peptide bond, and a gradient of acetonitrile in water separates the intact peptide from deletion sequences, oxidised products, and earlier-eluting fragments at neutral pH. Electrospray ionisation mass spectrometry provides an orthogonal check: the measured mass must agree with the theoretical value. Amino acid analysis and peptide mapping confirm structure but are used less often. Reference standards remain scarce because the peptide is not described in any pharmacopoeia.
Regulatory treatment varies by country. In the United States the peptide is not approved as a medicine, and products offered for human use may be treated as unapproved new drugs; some states also restrict sale. Australia, the United Kingdom, and European Union member states apply comparable restrictions to unapproved peptide products. Border agencies have seized shipments labelled as research chemicals. Classification may change over time, and the legal position for personal importation is not clearly settled in most published guidance.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
== References == Black, David; Bolton, Geoffrey (2001a). Biographical Register of Members of the Parliament of Western Australia. Vol. One: 1870–1930 (Revised ed.). Parliament House: Parliament of Western Australia. ISBN 0730738140. Hansard Indexes for 1933-1936, "Legislature of Western Australia" "Special (No.19)". Western Australia Government Gazette. 24 April 1933. p. 1933:621. Also 1935:727 (29 March 1935), 1936:684 (13 May 1936), 1936:1113 (23 July 1936) and 1936:1276 (20 August 1936).
=== Reactivity === Fialuridine's functional groups all influence its chemical activity. The iodine substituent at the 5-position of the pyrimidine ring is a bulky halogen that can participate in metal-halogen exchange in the presence of an organolithium reagent to synthesize 5-substituted nucleosides The pyrimidine base's carbonyl groups are electrophilic and capable of participating in hydrogen bonding and condensation reactions. Fluorine substitution in the furanose ring increases local electronegativity and influences the stability of neighbouring bonds like the glycosidic linkage. The β-N1 glycosidic bond is generally stable but can undergo acid-catalysed hydrolysis under harsh conditions.
Sweden and Finland are furthest along in committing to a particular disposal technology, while many others reprocess spent fuel or contract with France or Great Britain to do it, taking back the resulting plutonium and high-level waste. "An increasing backlog of plutonium from reprocessing is developing in many countries... It is doubtful that reprocessing makes economic sense in the present environment of cheap uranium." In many European countries (e.g., Britain, Finland, the Netherlands, Sweden, and Switzerland) the risk or dose limit for a member of the public exposed to radiation from a future high-level nuclear waste facility is considerably more stringent than that suggested by the International Commission on Radiation Protection or proposed in the United States. European limits are often more stringent than the standard suggested in 1990 by the International Commission on Radiation Protection by a factor of 20, and more stringent by a factor of ten than the standard proposed by the U.S. Environmental Protection Agency (EPA) for the Yucca Mountain nuclear waste repository for the first 10,000 years after closure. The U.S. EPA's proposed standard for greater than 10,000 years is 250 times more permissive than the European limit. The U.S.
Sources: en.wikipedia.org
To determine the need for referral to a specialized burn unit, the American Burn Association devised a classification system. Under this system, burns can be classified as major, moderate, and minor. This is assessed based on a number of factors, including total body surface area affected, the involvement of specific anatomical zones, the age of the person, and associated injuries. Minor burns can typically be managed at home, moderate burns are often managed in a hospital, and major burns are managed by a burn center. Severe burn injury represents one of the most devastating forms of trauma. Despite improvements in burn care, patients can be left to suffer for as many as three years post-injury.
=== Infectious dose === The infectious dose is the amount of agent that must be consumed to give rise to symptoms of foodborne illness, and varies according to the agent and the consumer's age and overall health. Pathogens vary in minimum infectious dose; for example, Shigella sonnei has a low estimated minimum dose of < 500 colony-forming units (CFU) while Staphylococcus aureus has a relatively high estimate. Importantly, prior exposure to pathogens can significantly increase an individual's tolerance to subsequent exposures. Locals in a region may tolerate pathogen levels that would cause illness in travelers due to immune memory developed from repeated low-level exposures. This helps explain why locals often consume food without illness that might sicken visitors. In the case of Salmonella a relatively large inoculum of 1 million to 1 billion organisms is necessary to produce symptoms in healthy human volunteers, as Salmonellae are very sensitive to acid. An unusually high stomach pH level (low acidity) greatly reduces the number of bacteria required to cause symptoms by a factor of between 10 and 100.
The fruit, commonly known as açaí or açaí berry, is a small, round, black-purple drupe about 25 mm (1 in) in circumference, similar in appearance to a grape, but smaller and with less pulp and produced in branched panicles of 500 to 900 fruits. The exocarp of the ripe fruits is a deep purple color, or green, depending on the kind of açaí and its maturity. The mesocarp is pulpy and thin, with a consistent thickness of 1 mm (0.04 in) or less. It surrounds the voluminous and hard endocarp, which contains a single large seed about 7–10 mm (0.3–0.4 in) in diameter. The seed makes up about 60–80% of the fruit. The palm bears fruit year round but the berry cannot be harvested during the rainy season. The açaí palm is a light-loving plant, and fruit yields greatly decrease in amount and quality if the plants are shaded.
== Mechanism of action == P7C3-A20 acts as a small-molecule activator of NAMPT, enhancing the conversion of nicotinamide to nicotinamide mononucleotide (NMN), a precursor to NAD+. This increases intracellular NAD+ levels, supporting cellular energy metabolism, mitochondrial function, and resistance to stress-induced cell death. Additional pathways reported in models include activation of PI3K/AKT/GSK3β signaling and restoration of NAD+ homeostasis without elevating NAD+ to supraphysiologic levels.
Sources: en.wikipedia.org
LEDs have many advantages over incandescent light sources, including lower power consumption, reduced waste heat, a longer lifetime, improved physical robustness, smaller sizes, and faster switching. In exchange for these generally favorable attributes, disadvantages of LEDs include electrical limitations to low voltage and generally to DC (not AC) power, the inability to provide steady illumination from a pulsing DC or an AC electrical supply source, and a lesser maximum operating temperature and storage temperature. LEDs are transducers of electricity into light.
=== Background === Proteins are essential macromolecules of living organisms. They are continuously being degraded into their constituent amino acids which can be reused in the synthesis of new proteins. Every cellular protein has its own half-life time. In humans, for instance, 50% of the liver and plasma proteins are replaced in 10 days, whereas in muscles it takes 180 days. On average, about 50% of our proteins are replaced every 80 days. Although the regulation of protein degradation is as important as their synthesis to keep cellular protein concentrations at optimum levels, research in this area remained until the end of the 1970s. Up to this time, lysosomes, discovered in the 1950s by the Belgian cytologist Christian de Duve, were thought responsible for the complete digestion of intra- and extracellular proteins by the lysosomal hydrolytic enzymes. Between the 1970s and 1980s, this view drastically changed. New experimental evidences showed that, under physiological conditions, non-lysosomal proteases were responsible for limited proteolysis of intra- and/or extracellular proteins, a concept originally conceived by Linderstᴓm-Lang in 1950. Endogenous or exogenous proteins are processed by non-lysosomal proteases into intermediate-sized polypeptides, which display gene and metabolic regulation, neurologic, endocrine, and immunological roles, whose dysfunction might explain a number of pathologies.
A full explanation requires considering the energy that would be released in forming compounds with different valences rather than simply considering electron configurations alone. For example, magnesium forms Mg2+ rather than Mg+ cations when dissolved in water, because the latter would spontaneously disproportionate into Mg0 and Mg2+ cations. This is because the enthalpy of hydration (surrounding the cation with water molecules) increases in magnitude with the charge and radius of the ion. In Mg+, the outermost orbital (which determines ionic radius) is still 3s, so the hydration enthalpy is small and insufficient to compensate the energy required to remove the electron; but ionizing again to Mg2+ uncovers the core 2p subshell, making the hydration enthalpy large enough to allow magnesium(II) compounds to form. For similar reasons, the common oxidation states of the heavier p-block elements (where the ns electrons become lower in energy than the np) tend to vary by steps of 2, because that is necessary to uncover an inner subshell and decrease the ionic radius (e.g. Tl+ uncovers 6s, and Tl3+ uncovers 5d, so once thallium loses two electrons it tends to lose the third one as well). Analogous arguments based on orbital hybridization can be used for the less electronegative p-block elements.
Sources: en.wikipedia.org
Dry powder is usually held frozen, shielded from light, and kept away from moisture. Desiccant packaging limits hydrolysis during storage. Solutions are typically aliquoted and frozen once, because repeated thawing shortens useful life.
Mass spectrometry establishes molecular mass, and reversed-phase chromatography reports purity. Peptide mapping or amino acid analysis supports sequence-level confirmation. No single technique covers all failure modes, so laboratories combine results.
Common entries include appearance, purity by chromatographic area, measured mass, and sometimes residual solvents or counter-ion content. Methods and instrument conditions are not always described. The document reflects the supplier's own testing unless an independent laboratory is named.
No. Melanotan-2 is manufactured synthetically. The naturally occurring peptide in the same family is alpha-melanocyte-stimulating hormone, which the body produces as part of normal endocrine and neural signalling.